An adaptation of the diabetes prevention program for use with high-risk, minority patients with type 2 diabetes

被引:36
|
作者
Cramer, J. Steven
Sibley, Ralph F.
Bartlett, Donald P.
Kahn, Linda S.
Loffredo, Lisa
机构
[1] SUNY Buffalo, Sch Med & Biomed Sci, Dept Family Med, Tonawanda, NY 14150 USA
[2] Kaleida Hlth, Buffalo, NY USA
来源
DIABETES EDUCATOR | 2007年 / 33卷 / 03期
关键词
D O I
10.1177/0145721707301680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE The purpose of this pilot study was to determine the effectiveness of an edited Diabetes Prevention Program (DPP) Lifestyle Resources Core Teaching Plan for managing patients with type 2 diabetes in an urban underserved setting. Modifications were made to attempt to cut to the bare essentials to work within the constrained budgets of safety net providers. The primary aim was to achieve a mean absolute reduction in HbA1c level of 1 percentage point. METHODS The authors conducted a randomized controlled trial of 9 months' duration for patients with type 2 diabetes with an HbA1c >= 8.0%. A total of 67 patients randomized into usual-care and case management groups were evaluated with an intention-to-treat analysis. A modified DPP workbook was used during 7 monthly visits with a nurse case manager. RESULTS As compared with the usual-care group, those in the case management group experienced a greater reduction in HbA1c level (-1.87 vs -0.54; P =.011) and weight (-2.47 kg vs +0.88 kg; P =.011). CONCLUSION Use of an edited version of the DPP workbook in an urban, low-income, minority population with type 2 diabetes produced a significant absolute reduction in HbA1c percentage and weight.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 50 条
  • [31] The beneficial effect of a comprehensive diabetes care model on high-risk relatives accompanying patients with type 2 diabetes
    Garcia-Ulloa, Ana C.
    Diaz-Pineda, Michelle
    Ramirez-Garcia, Alberto
    Antonio-Villa, Neftali Eduardo
    Almeda-Valdes, Paloma
    Kaufer-Horwitz, Martha
    Torres-Mejia, Gabriela
    Aguilar-Salinas, Carlos A.
    Hernandez-Jimenez, Sergio C.
    PRIMARY CARE DIABETES, 2022, 16 (06) : 791 - 796
  • [32] Lifetime health economic benefits of type 2 diabetes prevention in high risk subjects in an Australian setting: an updated analysis based on the results of the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
    Palmer, A. J.
    Tucker, D. M. D.
    DIABETOLOGIA, 2010, 53 : S83 - S83
  • [33] Type 2 diabetes pharmacotherapy trends in high-risk subgroups
    Bae, Jay
    Liu, Dongju
    Chinthammit, Chanadda
    Kadziola, Zbigniew
    Boye, Kristina
    Mather, Kieren
    DIABETES OBESITY & METABOLISM, 2022, 24 (06): : 1166 - 1171
  • [34] Screening for type 2 diabetes in a high-risk pediatric population
    Darby, P
    Grant, R
    Shapiro, A
    Redlener, I
    PEDIATRIC RESEARCH, 2003, 53 (04) : 156A - 156A
  • [35] Menopause and risk of diabetes in the Diabetes Prevention Program
    Kim, Catherine
    Edelstein, Sharon L.
    Crandall, Jill P.
    Dabelea, Dana
    Kitabchi, Abbas E.
    Hamman, Richard F.
    Montez, Maria G.
    Perreault, Leigh
    Foulkes, Mary A.
    Barrett-Connor, Elizabeth
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (08): : 857 - 868
  • [36] Menopause and Risk of Diabetes in the Diabetes Prevention Program
    Kim, Catherine
    Edelstein, Sharon E.
    Crandall, Jill P.
    Dabelea, Dana
    Kitabchi, Abbas E.
    Hamman, Richard F.
    Montez, Maria G.
    Perrault, Leigh
    Foulkes, Mary A.
    Barrett-Connor, Elizabeth
    DIABETES, 2011, 60 : A119 - A119
  • [37] Risk Communication and Use of Prevention services for Diabetes Mellitus Type 2 with the German Diabetes Risk Score
    Valenta, Vera
    Sailer, Corinna
    Muehlenbruch, Kristin
    Fritz, Jana
    Roller, Gottfried
    Kaiserauer, Andreas
    Mueller, Gerhard
    Haering, Hans-Ulrich
    Schulze, Matthias
    Fritsche, Andreas
    DIABETOLOGIE UND STOFFWECHSEL, 2019, 14 (02) : 132 - 138
  • [38] Statin Use and Risk of Developing Diabetes: Results from the Diabetes Prevention Program
    Rajpathak, Swapnil
    Temprosa, Marinella
    Haffner, Steve
    Mather, Kieren
    Watson, Karol
    Foo, Sandra
    Barrett-Connor, Elizabeth
    Crandall, Jill
    DIABETES, 2011, 60 : A354 - A355
  • [39] Statin use and risk of developing diabetes: results from the Diabetes Prevention Program
    Crandall, Jill P.
    Mather, Kieren
    Rajpathak, Swapnil N.
    Goldberg, Ronald B.
    Watson, Karol
    Foo, Sandra
    Ratner, Robert
    Barrett-Connor, Elizabeth
    Temprosa, Marinella
    BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [40] PUTTING THE DIABETES PREVENTION PROGRAM INTO PRACTICE: A PROGRAM FOR WEIGHT LOSS AND CARDIOVASCULAR RISK REDUCTION FOR PATIENTS WITH METABOLIC SYNDROME OR TYPE 2 DIABETES MELLITUS
    Mcbride, P. E.
    Einerson, J. A.
    Grant, H.
    Sargent, C.
    Underbakke, G.
    Vitcenda, M.
    Zeller, L.
    Stein, J. H.
    JOURNAL OF NUTRITION HEALTH & AGING, 2008, 12 (10): : 745S - 749S